Clene Inc. Common Stock

CLNNNASDAQ • USD
3.92 USD
↘ 0.08 (2.00%)AT CLOSE (03:59 PM EST)
3.98
↗ 0.06 (1.53%)
POST MARKET (AS OF 07:38 PM EST)
Post Market
AS OF 07:38 PM EST
3.98
↗ 0.06 (1.53%)
🔴Market: CLOSED

Shares of Clene Inc. Common Stock (CLNN) are trading at $3.91. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (181.2%) and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 13, 2026.

Open?$4.03
High?$4.43
Low?$3.86
Prev. Close?$4.00
Volume?28.7K
Avg. Volume?97.4K
VWAP?$4.00
Rel. Volume?0.30x
Bid / Ask
Bid?$3.80 × 100
Ask?$4.98 × 100
Spread?$1.18
Midpoint?$4.39
Valuation & Ratios
Market Cap?57.6M
Shares Out?14.4M
Float?9.3M
Float %?71.3%
P/E Ratio?N/A
P/B Ratio?-3.89
EPS?-$1.86
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Employees
79
Market Cap
57.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-12-31
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50
SALT LAKE CITY, UT 84121
Phone: 801-676-9695
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
57
Short Sent.?
49
Piotroski F-Score?4/9Mixed
Altman Z-Score?-22.95Distress
Confidence?55%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?4.50%Low
Short Interest?417.0K
Days to Cover?5.1
Free Float9.3M
Avg Daily Volume82.3K
Settlement Date2026-10-30
Financial Health
Current Ratio?0.85Weak
Quick Ratio?0.84Weak
Cash Ratio?0.58Adequate
Debt/Equity?-1.30Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-3.89CHEAP▾
P/S?
Peers
100
S&P
3
242.02HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.4CHEAP▾
EV/Sales?
Peers
100
S&P
3
281.20HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
181.2%STRONG▾
ROA?
S&P
3
-121.1%WEAK▾
Cash Flow & Enterprise
FCF?$-16612000
Enterprise Value?$66.9M
Fundamentals ratios updated end of day